Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity.

Watson BNJ, Vercoe RB, Salmond GPC, Westra ER, Staals RHJ, Fineran PC.

Nat Commun. 2019 Dec 4;10(1):5526. doi: 10.1038/s41467-019-13445-2.

2.

Expanding the mass range for UVPD-based native top-down mass spectrometry.

Greisch JF, Tamara S, Scheltema RA, Maxwell HWR, Fagerlund RD, Fineran PC, Tetter S, Hilvert D, Heck AJR.

Chem Sci. 2019 Jul 1;10(30):7163-7171. doi: 10.1039/c9sc01857c. eCollection 2019 Aug 14.

3.

The autoregulator Aca2 mediates anti-CRISPR repression.

Birkholz N, Fagerlund RD, Smith LM, Jackson SA, Fineran PC.

Nucleic Acids Res. 2019 Oct 10;47(18):9658-9665. doi: 10.1093/nar/gkz721.

4.

Global phylogeography and ancient evolution of the widespread human gut virus crAssphage.

Edwards RA, Vega AA, Norman HM, Ohaeri M, Levi K, Dinsdale EA, Cinek O, Aziz RK, McNair K, Barr JJ, Bibby K, Brouns SJJ, Cazares A, de Jonge PA, Desnues C, Díaz Muñoz SL, Fineran PC, Kurilshikov A, Lavigne R, Mazankova K, McCarthy DT, Nobrega FL, Reyes Muñoz A, Tapia G, Trefault N, Tyakht AV, Vinuesa P, Wagemans J, Zhernakova A, Aarestrup FM, Ahmadov G, Alassaf A, Anton J, Asangba A, Billings EK, Cantu VA, Carlton JM, Cazares D, Cho GS, Condeff T, Cortés P, Cranfield M, Cuevas DA, De la Iglesia R, Decewicz P, Doane MP, Dominy NJ, Dziewit L, Elwasila BM, Eren AM, Franz C, Fu J, Garcia-Aljaro C, Ghedin E, Gulino KM, Haggerty JM, Head SR, Hendriksen RS, Hill C, Hyöty H, Ilina EN, Irwin MT, Jeffries TC, Jofre J, Junge RE, Kelley ST, Khan Mirzaei M, Kowalewski M, Kumaresan D, Leigh SR, Lipson D, Lisitsyna ES, Llagostera M, Maritz JM, Marr LC, McCann A, Molshanski-Mor S, Monteiro S, Moreira-Grez B, Morris M, Mugisha L, Muniesa M, Neve H, Nguyen NP, Nigro OD, Nilsson AS, O'Connell T, Odeh R, Oliver A, Piuri M, Prussin Ii AJ, Qimron U, Quan ZX, Rainetova P, Ramírez-Rojas A, Raya R, Reasor K, Rice GAO, Rossi A, Santos R, Shimashita J, Stachler EN, Stene LC, Strain R, Stumpf R, Torres PJ, Twaddle A, Ugochi Ibekwe M, Villagra N, Wandro S, White B, Whiteley A, Whiteson KL, Wijmenga C, Zambrano MM, Zschach H, Dutilh BE.

Nat Microbiol. 2019 Oct;4(10):1727-1736. doi: 10.1038/s41564-019-0494-6. Epub 2019 Jul 8.

PMID:
31285584
5.

GalK limits type I-F CRISPR-Cas expression in a CRP-dependent manner.

Hampton HG, Patterson AG, Chang JT, Taylor C, Fineran PC.

FEMS Microbiol Lett. 2019 Jun 1;366(11). pii: fnz137. doi: 10.1093/femsle/fnz137.

PMID:
31226710
6.

Bacterial dormancy curbs phage epidemics.

Jackson SA, Fineran PC.

Nature. 2019 Jun;570(7760):173-174. doi: 10.1038/d41586-019-01595-8. No abstract available.

PMID:
31182829
7.

Genome Sequence of a Jumbo Bacteriophage That Infects the Kiwifruit Phytopathogen Pseudomonas syringae pv. actinidiae.

Wojtus JK, Frampton RA, Warring S, Hendrickson H, Fineran PC.

Microbiol Resour Announc. 2019 May 30;8(22). pii: e00224-19. doi: 10.1128/MRA.00224-19.

8.

A Unified Resource for Tracking Anti-CRISPR Names.

Bondy-Denomy J, Davidson AR, Doudna JA, Fineran PC, Maxwell KL, Moineau S, Peng X, Sontheimer EJ, Wiedenheft B.

CRISPR J. 2018 Oct;1:304-305. doi: 10.1089/crispr.2018.0043. No abstract available.

PMID:
31021273
9.

Resistance is not futile: bacterial 'innate' and CRISPR-Cas 'adaptive' immune systems.

Fineran PC.

Microbiology. 2019 Aug;165(8):834-841. doi: 10.1099/mic.0.000802. Epub 2019 Apr 8.

PMID:
30958259
10.

Genome-wide correlation analysis suggests different roles of CRISPR-Cas systems in the acquisition of antibiotic resistance genes in diverse species.

Shehreen S, Chyou TY, Fineran PC, Brown CM.

Philos Trans R Soc Lond B Biol Sci. 2019 May 13;374(1772):20180384. doi: 10.1098/rstb.2018.0384.

PMID:
30905286
11.

Reconstitution of CRISPR adaptation in vitro and its detection by PCR.

Fagerlund RD, Ferguson TJ, Maxwell HWR, Opel-Reading HK, Krause KL, Fineran PC.

Methods Enzymol. 2019;616:411-433. doi: 10.1016/bs.mie.2018.10.024. Epub 2019 Jan 12.

PMID:
30691653
12.

Imprecise Spacer Acquisition Generates CRISPR-Cas Immune Diversity through Primed Adaptation.

Jackson SA, Birkholz N, Malone LM, Fineran PC.

Cell Host Microbe. 2019 Feb 13;25(2):250-260.e4. doi: 10.1016/j.chom.2018.12.014. Epub 2019 Jan 17.

PMID:
30661951
13.

CRISPR-Cas impedes archaeal mating.

Fineran PC.

Nat Microbiol. 2019 Jan;4(1):2-3. doi: 10.1038/s41564-018-0326-0. No abstract available.

PMID:
30546095
14.

Phage-based biocontrol strategies and their application in agriculture and aquaculture.

Dy RL, Rigano LA, Fineran PC.

Biochem Soc Trans. 2018 Dec 17;46(6):1605-1613. doi: 10.1042/BST20180178. Epub 2018 Dec 4. Review.

PMID:
30514766
15.

Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systems.

Nicholson TJ, Jackson SA, Croft BI, Staals RHJ, Fineran PC, Brown CM.

RNA Biol. 2019 Apr;16(4):566-576. doi: 10.1080/15476286.2018.1509662. Epub 2018 Sep 18.

16.

Correction: Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems.

Silas S, Lucas-Elio P, Jackson SA, Aroca-Crevillén A, Hansen LL, Fineran PC, Fire AZ, Sánchez-Amat A.

Elife. 2018 Apr 4;7. pii: e36853. doi: 10.7554/eLife.36853. No abstract available.

17.

AbiEi Binds Cooperatively to the Type IV abiE Toxin-Antitoxin Operator Via a Positively-Charged Surface and Causes DNA Bending and Negative Autoregulation.

Hampton HG, Jackson SA, Fagerlund RD, Vogel AIM, Dy RL, Blower TR, Fineran PC.

J Mol Biol. 2018 Apr 13;430(8):1141-1156. doi: 10.1016/j.jmb.2018.02.022. Epub 2018 Mar 6.

PMID:
29518409
18.

CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction.

Watson BNJ, Staals RHJ, Fineran PC.

MBio. 2018 Feb 13;9(1). pii: e02406-17. doi: 10.1128/mBio.02406-17.

19.

Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems.

Silas S, Lucas-Elio P, Jackson SA, Aroca-Crevillén A, Hansen LL, Fineran PC, Fire AZ, Sánchez-Amat A.

Elife. 2017 Aug 17;6. pii: e27601. doi: 10.7554/eLife.27601. Erratum in: Elife. 2018 Apr 04;7:.

20.

Spacer capture and integration by a type I-F Cas1-Cas2-3 CRISPR adaptation complex.

Fagerlund RD, Wilkinson ME, Klykov O, Barendregt A, Pearce FG, Kieper SN, Maxwell HWR, Capolupo A, Heck AJR, Krause KL, Bostina M, Scheltema RA, Staals RHJ, Fineran PC.

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5122-E5128. doi: 10.1073/pnas.1618421114. Epub 2017 Jun 13.

Supplemental Content

Loading ...
Support Center